We are pleased to announce the following keynote speakers will be presenting at the conference - More to confirmed to be confirmed shortly!
|Professor Sharon Cameron MD, FRCOG, MFSRH
Consultant Gynaecologist, Chalmers Centre and the Royal Infirmary of Edinburgh and Professor (Hon) University of Edinburgh. She is Clinical Lead for Sexual Health Services in NHS Lothian. She is Co- director of Clinical Effectiveness Unit (Faculty of Sexual and Reproductive Healthcare). Her international roles include member of the Steering committee of World Health Organization Medical Eligibility Criteria for Contraceptive Use, President of International Federation of Abortion and Contraception Professionals (FIAPAC), and deputy chair of the Internal Scientific Committee of the European Society for contraception. She has over 20 years of clinical research experience in field of contraception and sexual and reproductive health.
|Dr. Jake Estes
Dr. Jake Estes is a Professor in the Vaccine and Gene Therapy Institute (VGTI) and Chief of the Division of Pathobiology & Immunology at the Oregon National Primate Research Center (ONPRC) at Oregon Health & Science University (OHSU).
|Dr. Jason Farley
Dr. Jason Farley is an Associate Professor at Johns Hopkins University School of Nursing and a nurse practitioner in the Division of Infectious Diseases at Johns Hopkins Medicine. Dr. Farley’s portfolio of research includes the development of multi-component interventions designed to improve the HIV treatment and prevention cascade of care which extends to interventions for patients with HIV and TB co-infection. Through innovative technological solutions, improvements and advancement of task-sharing approaches, or nurse and/or peer case management interventions, Dr. Farley’s work has a large clinical impact. He presently leads The Johns Hopkins HIV Prevention Trials Network (HPTN) within the School of Medicine and is the Founder of The REACH Initiative of Johns Hopkins University School of Nursing. He also directs the DNP/PhD Clinical Research Scientist Program. He is the immediate past President of the Association of Nurses in AIDS Care (ANAC), the world's largest HIV focused nursing organization.
|Professor Adeeba Kamarulzaman
Professor Adeeba Kamarulzaman graduated from Monash University and trained in internal medicine and infectious diseases in Melbourne, Australia. She is presently the Dean of the Faculty of Medicine, University of Malaya and an Adjunct Associate Professor at Yale University, USA.
Her research effort focuses on HIV amongst key populations especially among people who use drugs. She is presently a member of the WHO Expert Advisory Panel on Health Science & Technology Policy, is President-Elect of the International AIDS Society and a member of the UNAIDS Scientific Expert Panel on HIV and TREAT Asia.
Professor Kamarulzaman was the first recipient of the Australian Advance Global Award in the category of Alumni in 2012 and in April 2015 she received a Doctor of Laws (honoris causa) from her alma mater, Monash University for her achievements in medicine and as a health advocate.
Richard Parker is Professor Emeritus of Sociomedical Sciences and Anthropology and a member of the Committee on Global Thought at Columbia University in New York City and Senior Visiting Professor in the Institute for the Study of Collective Health at the Federal University of Rio de Janeiro. He is also the Director and President of the Brazilian Interdisciplinary AIDS Association (ABIA), a leading non-governmental AIDS organization in Brazil, as well as founder and Co-Chair of Sexuality Policy Watch, a global coalition of researchers, policymakers and activists and Editor-in-Chief of Global Public Health. He has conducted research in Brazil since the early 1980s, as well as comparative studies in Vietnam, South Africa, and the USA on inequality, stigma, and discrimination, the politics of global health and the role of social movements responding to key public health challenges. He is the author of more than scholarly 250 publications.
|Prof. Anthony Kelleher
Tony Kelleher is Director of the Kirby Institute, UNSW Sydney. He is a clinician scientist, trained in internal medicine and pathology.
He has played a role in multiple phase I- to phase IV clinical trials and cohort studies exploring the treatment and prevention of HIV infection, especially in the conduct of correlative immuno-virological studies. He has established novel assays for the measurement of CD4+ T cell responses, and the use of fine needle biopsies of lymph nodes to study both immune responses and the HIV reservoir. He is also exploring an siRNA based “block and lock” strategy for the control of the viral reservoir.
Photo credit to Aisyah Sumito
Shoshana Rosenberg is a sexological researcher based between Whadjuk Noongar Boodjar (Perth) and Naarm/Birraranga (Melbourne). They are currently working with the Kirby Institute (UNSW) and SiREN (Curtin) on a variety of sexual health projects. Their research interests include gender and sexual diversity, queer theory, Jewish studies, and musicology.
|Dr David Speers
Dr David Speers is an ID Physician, Sir Charles Gairdner Hospital, Chair of Microbiology, PathWest Laboratory Medicine WA and Clinical Associate Professor for the Department of Medicine, University of WA. He is a fellow of the Royal Australasian College of Physicians, the Royal College of Pathologists of Australasia, and the Australasian College of Tropical Medicine.
|A/Prof. James Ward
Associate Professor James Ward is a Pitjantjatjara/ Narungga man, and a national leader in Aboriginal and Torres Strait Islander research. He is Head of the Infectious Diseases Research Program, Aboriginal Health, at the South Australian Health and Medical Research Institute.
In 2017, the NHMRC awarded James with the Rising Star Research Excellence Award for the top-ranked application by an Indigenous researcher in the Early Career Fellowship scheme. In the same year, James was also awarded the NAIDOC SA Scholar of the Year. In 2018 James was awarded the Viertel Senior Medical Research Fellowship - Australia’s most prestigious fellowship.
Throughout his health and research career, James has demonstrated a true commitment to improving the health and wellbeing of Aboriginal and Torres Strait Islander adolescents, and a dedication to awareness, education, dissemination advocacy and community engagement.
James has been awarded funding applications in the area of STI’s/ BBV’s/ AOD totalling $23M since 2013 and has authored over 100 publications.